Mannatech (NASDAQ:MTEX – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “buy” rating in a report issued on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings upgraded Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, October 29th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on MTEX
Mannatech Price Performance
Shares of MTEX stock opened at $8.11 on Friday. The company has a market capitalization of $15.65 million, a PE ratio of -2.07 and a beta of 0.62. The firm’s 50-day moving average is $7.87 and its two-hundred day moving average is $6.33. Mannatech has a 12 month low of $3.80 and a 12 month high of $9.97.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.53 earnings per share for the quarter. The business had revenue of $26.65 million during the quarter. Mannatech had a negative net margin of 6.90% and a negative return on equity of 2,383.34%.
About Mannatech
Mannatech, Incorporated develops and markets nutritional supplements, health and wellness products, and personal-care products through a direct-selling business model. Its product offerings have included dietary supplements, functional nutrition products, weight-management formulas, and skin-care products, with an emphasis on ingredients intended to support general wellness and healthy aging.
The company is best known for its Ambrotose product line, which incorporates plant-sourced polysaccharides, as well as related nutritional supplements and wellness programs.
Further Reading
- Five stocks we like better than Mannatech
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
